News Detail
Mumbai, 14 March 2023: The National Medical Commission (NMC) has directed all the recognized medical colleges and standalone PG institutions to get them enrolled with Indian Pharmacopoeia Commission (IPC) as Adverse Drug Reaction Monitoring Centres (AMCs) at the earliest towards ......
View Details
Source : Pharmabiz
National Medical Commission
NMC
PG institutions
Indian Pharmacopoeia Commission
IPC
Adverse Drug Monitoring Centres
AMCs
adverse drug reactions
ADRs
PvPI
NMC Act 2019
WHO
Related News
- Indian Patent Office to hear objections on Gilead's HIV drug patent claims (18-09-2024)
- CDSCO revises guidance document for functions & responsibilities of zonal, sub-zonal & port offices (18-09-2024)
- India exported drugs and pharma worth $11.9 bn in April-August 2024 (18-09-2024)
- US FDA releases draft guidance on oncology multiregional clinical trials (18-09-2024)
- Narcotists raid in UP-Uttarakhand, fake medicines worth three crores, machines worth eight crores seized, five arrested (18-09-2024)
- DCC recommends making Sugam portal database of all products with brand names (17-09-2024)
- CDSCO releases draft guidelines on good clinical practices for consultation (17-09-2024)
- One-third of India’s 30 lakh sepsis deaths linked to antimicrobial resistance (17-09-2024)
- Pharmacist practicing without degree, 35 types of medicines and surgical equipments seized (17-09-2024)
- CDSCO to switch Form 44 submission online (16-09-2024)